NatWest Group’s Idexx Laboratories IDXX Stock Holding History

NatWest Group’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q4	–	Sell	-14,746	Closed	-$735K	–	815
2013 Q3	$735K	Buy	+14,746	New	+$709K	0.02%	541

Other funds holding IDXX

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

RCG

Ruane, Cunniff & Goldfarb New York $6.43B AUM 18.44% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

NatWest Group's IDXX Position: Q4 2013 in Review

NatWest Group sold out of Idexx Laboratories (IDXX) in Q4 2013, closing a stake of 14,746 shares — an estimated $735K sold.

NatWest Group first reported a position in IDXX in Q3 2013 and held it in 1 quarter. The position peaked at $735K in Q3 2013. 298 funds tracked by Wall St. Rank hold IDXX as of Q4 2013.

NatWest Group reported no remaining Idexx Laboratories position as of Q4 2013 after selling out during the quarter.
NatWest Group sold 14,746 Idexx Laboratories shares in Q4 2013, an estimated $735K.
NatWest Group first reported a position in Idexx Laboratories in Q3 2013 and held it in 1 quarter.
NatWest Group's Idexx Laboratories position peaked at $735K in Q3 2013.
298 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2013.

Based on NatWest Group's 13F filing for Q4 2013, filed 13 Feb 2014.